Deutsche Bank
TYRA icon

Deutsche Bank’s Tyra Biosciences TYRA Stock Holding History

Deutsche Bank’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$785K Buy
20,495
+4,118
+25% +$133K ﹤0.01% 2327
2025
Q4 		$431K Buy
16,377
+894
+6% +$16.4K ﹤0.01% 2657
2025
Q3 		$217K Buy
15,483
+2,183
+16% +$24.9K ﹤0.01% 3027
2025
Q2 		$127K Sell
13,300
-3,679
-22% -$35K ﹤0.01% 3169
2025
Q1 		$158K Sell
16,979
-1,930
-10% -$25K ﹤0.01% 3057
2024
Q4 		$263K Buy
18,909
+6,466
+52% +$117K ﹤0.01% 2975
2024
Q3 		$293K Buy
12,443
+3,116
+33% +$65.4K ﹤0.01% 2734
2024
Q2 		$149K Buy
9,327
+3,314
+55% +$57K ﹤0.01% 2968
2024
Q1 		$98.6K Sell
6,013
-210
-3% -$3.44K ﹤0.01% 3180
2023
Q4 		$86.2K Hold
6,223
– – ﹤0.01% 3288
2023
Q3 		$85.7K Hold
6,223
– – ﹤0.01% 3228
2023
Q2 		$106K Sell
6,223
-1,915
-24% -$27.8K ﹤0.01% 3249
2023
Q1 		$131K Buy
8,138
+3,127
+62% +$37.2K ﹤0.01% 3203
2022
Q4 		$38.1K Buy
5,011
+89
+2% +$629 ﹤0.01% 3639
2022
Q3 		$43K Sell
4,922
-875
-15% -$8K ﹤0.01% 3637
2022
Q2 		$41K Sell
5,797
-816
-12% -$6.5K ﹤0.01% 3815
2022
Q1 		$71K Sell
6,613
-776
-11% -$9.21K ﹤0.01% 3712
2021
Q4 		$104K Buy
+7,389
New +$147K ﹤0.01% 3685

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Deutsche Bank's TYRA Position: Q1 2026 in Review

Deutsche Bank increased its Tyra Biosciences (TYRA) stake by 25% in Q1 2026, buying an estimated $133K and bringing the position to 20,495 shares worth $785K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

Deutsche Bank first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Deutsche Bank held 20,495 shares of Tyra Biosciences worth $785K as of Q1 2026.
  • Deutsche Bank bought 4,118 Tyra Biosciences shares in Q1 2026, an estimated $133K.
  • Tyra Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2327 holding.
  • Deutsche Bank first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.